我武生物(300357) - 2017 Q3 - 季度财报

Financial Performance - Revenue for the reporting period was CNY 128,489,524.37, representing a 22.31% increase year-on-year[9] - Net profit attributable to shareholders increased by 43.98% to CNY 69,758,455.30 compared to the same period last year[9] - Basic earnings per share rose by 44.00% to CNY 0.4317[9] - The weighted average return on net assets increased by 1.56% to 9.57% for the reporting period[9] - The net profit for the third quarter of 2017 reached CNY 69,758,455.30, compared to CNY 48,449,776.71 in the previous year, marking an increase of about 43.9%[38] - The total profit for the third quarter was CNY 82,235,953.24, compared to CNY 58,657,805.13 in the previous year, which is an increase of approximately 40.2%[38] - The basic and diluted earnings per share for the third quarter were both CNY 0.4317, up from CNY 0.2998 in the same period last year, representing an increase of about 43.9%[39] - The total comprehensive income for the third quarter was CNY 69,751,334.64, compared to CNY 48,452,272.35 in the previous year, reflecting an increase of approximately 43.9%[39] - The net profit for Q3 2017 reached CNY 148,488,519.77, representing a growth of 44.8% from CNY 102,579,185.40 in Q3 2016[47] - The total profit for Q3 2017 was CNY 175,080,072.00, which is a 43.0% increase compared to CNY 122,377,072.95 in Q3 2016[46] Assets and Liabilities - Total assets increased by 15.64% to CNY 805,912,927.01 compared to the end of the previous year[9] - The total liabilities increased to CNY 42,265,167.69 from CNY 41,317,893.41, indicating a rise of 2.3%[31] - Accounts receivable increased by 44,375,819.90 yuan, up 57.79%, due to increased sales revenue and corresponding credit sales[17] - Inventory rose by 6,368,587.74 yuan, up 45.36%, attributed to expanded sales scale and increased inventory reserves[17] - Cash and cash equivalents decreased to CNY 165,407,344.64 from CNY 222,835,118.91, a decline of 26%[33] - Cash and cash equivalents at the end of the period were CNY 165,407,344.64, down from CNY 221,171,518.96 at the end of the same period last year, a decrease of 25.2%[56] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 118,117,953.32, up 29.64%[9] - Net cash flow from operating activities increased by 27,008,741.35 yuan, up 29.64%, primarily due to higher cash received from sales[20] - The cash flow from operating activities for Q3 2017 was CNY 118,117,953.32, an increase of 29.7% from CNY 91,109,211.97 in the same quarter last year[53] - The total cash inflow from operating activities was CNY 273,506,577.59, an increase of 20.5% from CNY 226,867,082.76 in Q3 2016[53] - Operating cash flow net amount for the third quarter was CNY 120,053,866.53, an increase of 29.3% compared to CNY 92,813,009.90 in the same period last year[55] - Total cash inflow from investment activities was CNY 646,649,177.99, significantly higher than CNY 272,956,561.89 in the previous year, marking an increase of 137.5%[55] - Cash outflow from investment activities totaled CNY 783,723,028.24, compared to CNY 351,637,520.25 in the same period last year, representing an increase of 123.3%[55] - The net cash flow from investment activities was -CNY 137,073,850.25, worsening from -CNY 78,680,958.36 year-over-year[55] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,360[13] - The largest shareholder, Zhejiang Wowo Management Consulting Co., Ltd., held 38.86% of the shares[13] Other Financial Metrics - The company reported non-recurring gains and losses totaling CNY 6,535,667.36 for the year-to-date[10] - Development expenses increased by 11,463,391.57 yuan, up 36.27%, due to ongoing R&D investments in projects like Artemisia annua extract[17] - Other income increased by 1,870,599.22 yuan, a rise of 397.78%, primarily due to increased government subsidies received[19] - Investment income increased by 3,469,208.91 yuan, a growth of 169.46%, mainly from increased purchases of bank wealth management products[19] - The asset impairment loss for the third quarter was CNY 2,025,845.05, compared to CNY 1,696,376.82 in the previous year, indicating an increase of about 19.4%[38] - The investment income for the third quarter was CNY 2,473,546.13, significantly higher than CNY 264,904.11 in the previous year, marking an increase of approximately 834.5%[38] Reporting and Audit - The company did not conduct an audit for the third quarter report[57] - The report was released on October 26, 2017, by the legal representative Hu Gengxi[58]